NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit After Tax | ₹170 Cr | ₹442 Cr | ₹458 Cr | ₹642 Cr | ₹695 Cr |
What is the latest Profit After Tax of NATCO PHARMA ?
Year | Profit After Tax |
---|---|
Mar2023 | ₹170 Cr |
Mar2022 | ₹442 Cr |
Mar2021 | ₹458 Cr |
Mar2020 | ₹642 Cr |
Mar2019 | ₹695 Cr |
How is Profit After Tax of NATCO PHARMA Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹170 Cr | -61.57 | |
Mar2022 | ₹442 Cr | -3.43 | |
Mar2021 | ₹458 Cr | -28.69 | |
Mar2020 | ₹642 Cr | -7.59 | |
Mar2019 | ₹695 Cr | - |
Compare Profit After Tax of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹18,508.2 Cr | 0.2% | 6% | 76% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 0.2% |
6% |
76% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses